Nanalysis Scientific (CVE:NSCI) Reaches New 1-Year Low – What’s Next?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The stock traded as low as C$0.15 and last traded at C$0.15, with a volume of 193458 shares trading hands. The stock had previously closed at C$0.15.

Nanalysis Scientific Stock Performance

The stock has a market capitalization of C$17.22 million, a price-to-earnings ratio of -1.50 and a beta of -0.91. The company’s fifty day simple moving average is C$0.18 and its 200 day simple moving average is C$0.21. The company has a quick ratio of 1.11, a current ratio of 1.42 and a debt-to-equity ratio of 71.72.

Nanalysis Scientific Company Profile

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Featured Stories

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.